Reply to high cost of immunoglobulin replacement therapy: Causes and implications

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of allergy, asthma, & immunology asthma, & immunology, 2023-02, Vol.130 (2), p.258-258
1. Verfasser:	Wasserman, Richard L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Humans Immunization, Passive Immunoglobulins - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	258
container_issue	2
container_start_page	258
container_title	Annals of allergy, asthma, & immunology
container_volume	130
creator	Wasserman, Richard L.
description
doi_str_mv	10.1016/j.anai.2022.11.005
format	Article
fullrecord	<record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2735877601</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1081120622019111</els_id><sourcerecordid>2735877601</sourcerecordid><originalsourceid>FETCH-LOGICAL-e264t-102858be2060c99ddd7bb94f3647fdf05e8fb5298225997fcab49070d388faa73</originalsourceid><addsrcrecordid>eNo10E1r3DAQgGFREpLtNn-gh6BjLnZHH5blkEtYkiawUBLSs5ClcVaLbTmWXdh_Xy-bnGYOD8PwEvKTQc6AqV_73PY25Bw4zxnLAYpvZMUKITMphTpbdtAsYxzUJfme0h4AmFbiglwKJZRWUq7IyysO7YFOke7C-466mCYaGxq6bu7jexvruQ09HRdkHXbYT3Ta4WiHwy3d2Dlhorb3Cx_a4OwUYp9-kPPGtgmvPuea_H18eNs8Zds_v58399sMuZJTxoDrQte4fAeuqrz3ZV1XshFKlo1voEDd1AWvNOdFVZWNs7WsoAQvtG6sLcWa3JzuDmP8mDFNpgvJYdvaHuOcDC9FoctSAVvo9Sed6w69GcbQ2fFgvjIs4O4EcHn4X8DRJBewd-jDiG4yPgbDwByrm705VjfH6oYxs1QX_wFrp3TF</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2735877601</pqid></control><display><type>article</type><title>Reply to high cost of immunoglobulin replacement therapy: Causes and implications</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Wasserman, Richard L.</creator><creatorcontrib>Wasserman, Richard L.</creatorcontrib><identifier>ISSN: 1081-1206</identifier><identifier>EISSN: 1534-4436</identifier><identifier>DOI: 10.1016/j.anai.2022.11.005</identifier><identifier>PMID: 36368644</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Humans ; Immunization, Passive ; Immunoglobulins - therapeutic use</subject><ispartof>Annals of allergy, asthma, & immunology, 2023-02, Vol.130 (2), p.258-258</ispartof><rights>2022 American College of Allergy, Asthma & Immunology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-3447-4859</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.anai.2022.11.005$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36368644$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wasserman, Richard L.</creatorcontrib><title>Reply to high cost of immunoglobulin replacement therapy: Causes and implications</title><title>Annals of allergy, asthma, & immunology</title><addtitle>Ann Allergy Asthma Immunol</addtitle><subject>Humans</subject><subject>Immunization, Passive</subject><subject>Immunoglobulins - therapeutic use</subject><issn>1081-1206</issn><issn>1534-4436</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo10E1r3DAQgGFREpLtNn-gh6BjLnZHH5blkEtYkiawUBLSs5ClcVaLbTmWXdh_Xy-bnGYOD8PwEvKTQc6AqV_73PY25Bw4zxnLAYpvZMUKITMphTpbdtAsYxzUJfme0h4AmFbiglwKJZRWUq7IyysO7YFOke7C-466mCYaGxq6bu7jexvruQ09HRdkHXbYT3Ta4WiHwy3d2Dlhorb3Cx_a4OwUYp9-kPPGtgmvPuea_H18eNs8Zds_v58399sMuZJTxoDrQte4fAeuqrz3ZV1XshFKlo1voEDd1AWvNOdFVZWNs7WsoAQvtG6sLcWa3JzuDmP8mDFNpgvJYdvaHuOcDC9FoctSAVvo9Sed6w69GcbQ2fFgvjIs4O4EcHn4X8DRJBewd-jDiG4yPgbDwByrm705VjfH6oYxs1QX_wFrp3TF</recordid><startdate>202302</startdate><enddate>202302</enddate><creator>Wasserman, Richard L.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3447-4859</orcidid></search><sort><creationdate>202302</creationdate><title>Reply to high cost of immunoglobulin replacement therapy: Causes and implications</title><author>Wasserman, Richard L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e264t-102858be2060c99ddd7bb94f3647fdf05e8fb5298225997fcab49070d388faa73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Humans</topic><topic>Immunization, Passive</topic><topic>Immunoglobulins - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wasserman, Richard L.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of allergy, asthma, & immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wasserman, Richard L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reply to high cost of immunoglobulin replacement therapy: Causes and implications</atitle><jtitle>Annals of allergy, asthma, & immunology</jtitle><addtitle>Ann Allergy Asthma Immunol</addtitle><date>2023-02</date><risdate>2023</risdate><volume>130</volume><issue>2</issue><spage>258</spage><epage>258</epage><pages>258-258</pages><issn>1081-1206</issn><eissn>1534-4436</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>36368644</pmid><doi>10.1016/j.anai.2022.11.005</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-3447-4859</orcidid></addata></record>
fulltext	fulltext
identifier	ISSN: 1081-1206
ispartof	Annals of allergy, asthma, & immunology, 2023-02, Vol.130 (2), p.258-258
issn	1081-1206 1534-4436
language	eng
recordid	cdi_proquest_miscellaneous_2735877601
source	MEDLINE; Access via ScienceDirect (Elsevier)
subjects	Humans Immunization, Passive Immunoglobulins - therapeutic use
title	Reply to high cost of immunoglobulin replacement therapy: Causes and implications
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T11%3A18%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reply%20to%20high%20cost%20of%20immunoglobulin%20replacement%20therapy:%20Causes%20and%20implications&rft.jtitle=Annals%20of%20allergy,%20asthma,%20&%20immunology&rft.au=Wasserman,%20Richard%20L.&rft.date=2023-02&rft.volume=130&rft.issue=2&rft.spage=258&rft.epage=258&rft.pages=258-258&rft.issn=1081-1206&rft.eissn=1534-4436&rft_id=info:doi/10.1016/j.anai.2022.11.005&rft_dat=%3Cproquest_pubme%3E2735877601%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2735877601&rft_id=info:pmid/36368644&rft_els_id=S1081120622019111&rfr_iscdi=true